| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.700 | None | 0.939 | 98 | 2 | 1980 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.700 | None | 0.857 | 35 | 8 | 2007 | 2019 | ||||||||
|
endoplasmic reticulum aminopeptidase 1 | 0.556 | 0.692 | 2.1E-26 |
|
disease | 0.700 | None | 1.000 | 24 | 6 | 2013 | 2020 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.670 | None | 1.000 | 8 | 4 | 2010 | 2019 | ||||||||
|
killer cell lectin like receptor C4 | 0.666 | 0.654 | 5.7E-03 |
|
disease | 0.630 | None | 1.000 | 4 | 1 | 2013 | 2017 | ||||||||
|
C-C motif chemokine receptor 1 | 0.531 | 0.769 | 0.39 |
|
disease | 0.540 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
disease | 0.500 | None | 1.000 | 21 | 9 | 2000 | 2019 | ||||||||
|
IL12A antisense RNA 1 | 0.633 | 0.654 |
|
disease | 0.410 | None | 1.000 | 4 | 2 | 2013 | 2016 | |||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.400 | None | 0.875 | 24 | 5 | 2010 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.846 | 13 | 0 | 1996 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.400 | None | 0.900 | 10 | 2 | 2008 | 2016 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
disease | 0.400 | None | 1.000 | 3 | 3 | 2012 | 2013 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.380 | None | 1.000 | 10 | 2 | 1996 | 2016 | ||||||||
|
UBA domain containing 2 | 0.638 | 0.654 | 6.3E-03 |
|
disease | 0.340 | None | 1.000 | 4 | 4 | 2009 | 2017 | ||||||||
|
integrin subunit beta 2 | 0.444 | 0.923 | 5.1E-15 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 1996 | 2017 | ||||||||
|
integrin subunit alpha L | 0.511 | 0.885 | 4.3E-03 |
|
disease | 0.330 | None | 1.000 | 4 | 1 | 1996 | 2017 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2005 | 2015 | ||||||||
|
interleukin 12A | 0.491 | 0.808 | 4.7E-02 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2008 | 2016 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2002 | 2003 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.200 | None | 0.885 | 26 | 1 | 1997 | 2019 |